Search -

Displaying 101 - 120 of 176

Sort: Relevancy | Date

News Daily News

FDA: Another Class I Recall for HeartWare VAD

Shelley Wood

April 16, 2021

News Daily News

Hints of Benefit With Levosimendan in Pulmonary Hypertension Due to HFpEF

Michael O'Riordan

April 15, 2021

News Daily News

FDA: Class I Recall for HeartWare VAD Pump Implant Kit

Shelley Wood

March 01, 2021

News Daily News

Safe to Upgrade From Pacemaker or Defibrillator to CRT

Michael O'Riordan

February 10, 2021

News Conference News HFSA 2020

Splanchnic Nerve Ablation Improves HFpEF Symptoms, QoL in FIH Study

L.A. McKeown

October 12, 2020

News Daily News

ECMO in AMICS: Amid Few Prospective Trials, a Multicenter Registry Yields Insights

Caitlin E. Cox

August 18, 2020

News Daily News

ViV TAVR Beats Redo SAVR for Short- but Not Long-term Outcomes

L.A. McKeown

July 27, 2020

News Daily News

COVID-19 Patients With Arterial Leg Thromboses Risk Amputation and Death

L.A. McKeown

July 23, 2020

News Conference News HRS 2020

Permanent Conduction-System Pacing After TAVR? Don’t ‘Diss the His’

Michael O'Riordan

May 21, 2020

News Daily News

Don’t Overlook COVID-19’s Cardiovascular Footprint, Say NYC Physicians

Caitlin E. Cox

April 09, 2020

News Conference News STS 2020

PE for Surgeons: Be Active Participants in Team-Based Care, Experts Urge

Yael L. Maxwell

February 03, 2020

News Daily News

Optimal Implantation Depth With Self-Expanding TAVR? Success May Prove Elusive

Yael L. Maxwell

December 19, 2019

News Daily News

SCAI Shock Definition Tracks Well With Mortality in Cardiac ICU

Todd Neale

September 24, 2019

News Conference News ESC Heart Failure 2019

Early Peek Hints at Safety and Utility of V-LAP Sensor for Monitoring Left Atrial Pressure

Shelley Wood

May 29, 2019

News Conference News SCAI 2019

National Cardiogenic Shock Initiative Shows Potential to Increase Survival

Yael L. Maxwell

May 23, 2019

News Conference News SCAI 2019

New Cardiogenic Shock Definitions Create Common Lexicon for Healthcare Teams

Yael L. Maxwell

May 22, 2019

News Daily News

Proportionate and Disproportionate MR: A ‘Framework’ for MitraClip and Medical Therapy

Shelley Wood

May 09, 2019

News Industry News

VisCardia Announces Completion of Enrollment and Three Month Follow-Up Visits for Its VisONE® Heart Failure Pilot Study

April 22, 2019

News Conference News ACC 2019

Final MOMENTUM 3 Results Secure Superiority Claim for HeartMate 3 LVAD

Shelley Wood

March 22, 2019

News Conference News ACC 2019

CardioMEMS Postapproval Study Linked to Reduction in Heart Failure Hospitalizations at 1 Year

Yael L. Maxwell

March 20, 2019

Advertisement

FDA: Another Class I Recall for HeartWare VAD

Hints of Benefit With Levosimendan in Pulmonary Hypertension Due to HFpEF

FDA: Class I Recall for HeartWare VAD Pump Implant Kit

Safe to Upgrade From Pacemaker or Defibrillator to CRT

Splanchnic Nerve Ablation Improves HFpEF Symptoms, QoL in FIH Study

ECMO in AMICS: Amid Few Prospective Trials, a Multicenter Registry Yields Insights

ViV TAVR Beats Redo SAVR for Short- but Not Long-term Outcomes

COVID-19 Patients With Arterial Leg Thromboses Risk Amputation and Death

Permanent Conduction-System Pacing After TAVR? Don’t ‘Diss the His’

Don’t Overlook COVID-19’s Cardiovascular Footprint, Say NYC Physicians

PE for Surgeons: Be Active Participants in Team-Based Care, Experts Urge

Optimal Implantation Depth With Self-Expanding TAVR? Success May Prove Elusive

SCAI Shock Definition Tracks Well With Mortality in Cardiac ICU

Early Peek Hints at Safety and Utility of V-LAP Sensor for Monitoring Left Atrial Pressure

National Cardiogenic Shock Initiative Shows Potential to Increase Survival

New Cardiogenic Shock Definitions Create Common Lexicon for Healthcare Teams

Proportionate and Disproportionate MR: A ‘Framework’ for MitraClip and Medical Therapy

VisCardia Announces Completion of Enrollment and Three Month Follow-Up Visits for Its VisONE® Heart Failure Pilot Study

Final MOMENTUM 3 Results Secure Superiority Claim for HeartMate 3 LVAD

CardioMEMS Postapproval Study Linked to Reduction in Heart Failure Hospitalizations at 1 Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content